| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | VERSARTIS INC COM | 2,039,223 | 30,384,000 | 21.76% | ||
| 2 | EDGE THERAPEUTICS INC | 2,344,868 | 29,311,000 | 20.99% | ||
| 3 | Oxford Immunotec Global PLC | 1,377,497 | 20,594,000 | 14.75% | ||
| 4 | WAVE LIFE SCIENCES LTD | 658,259 | 17,213,000 | 12.33% | ||
| 5 | Crispr Therapeutics | 586,475 | 11,882,000 | 8.51% | ||
| 6 | DIMENSION THERAPEUTICS INC COM | 2,059,283 | 8,958,000 | 6.42% | ||
| 7 | SAGE THERAPEUTICS | 114,123 | 5,827,000 | 4.17% | ||
| 8 | DERMIRA INC | 177,844 | 5,394,000 | 3.86% | ||
| 9 | ALDER BIOPHARMACEUTICALS INC | 228,428 | 4,751,000 | 3.40% | ||
| 10 | AVEO PHARMACEUTICALS INC | 2,590,673 | 1,399,000 | 1.00% | ||
| 11 | VistaGen Therapeutics Inc | 352,950 | 1,317,000 | 0.94% | ||
| 12 | DYNAVAX TECHNOLOGIES CORP | 256,381 | 1,013,000 | 0.73% | ||
| 13 | LOMBARD MEDICAL INC | 1,072,634 | 643,000 | 0.46% | ||
| 14 | TRILLIUM THERAPEUTICS INC | 96,759 | 547,000 | 0.39% | ||
| 15 | INOTEK PHARMACEUTICALS CORP | 62,300 | 380,000 | 0.27% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001012975-17-000134, filed 2017.02.14).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
